Conclusions:
Among community-dwelling older men, the association between lower 25(OH)D and sleep apnea was largely explained by confounding by larger BMI and neck circumference.
Introduction:
Obstructive sleep apnea (OSA) is a disease of recurrent, partial or complete upper airway closure during sleep. The pathogenesis of OSA is complex 1 and a recent study reported increased OSA incidence and severity during winter months concentrations are also associated with airway inflammation, chronic rhinitis and repeated upper airway infections leading to tonsillar enlargement [6] [7] [8] [9] [10] , which may additionally contribute to OSA incidence and severity. Low 25(OH)D concentrations are also associated with type 2 diabetes mellitus, metabolic syndrome and obesity, all of which are frequently found in patients with OSA 11, 12 .
Only a few studies have studied the association between lower 25(OH)D levels and OSA and these have reported inconsistent results [13] [14] [15] .
To better address this knowledge gap, we analyzed data from a large, multi-center, community-based cohort study and tested the hypothesis that lower blood concentrations of 25(OH)D are associated with greater prevalence and increased severity of OSA, independent of classic OSA risk factors.
Methods: Study participants
The Osteoporotic Fractures in Men (MrOS) Study enrolled 5,995 communitydwelling men aged 65 and older during the baseline examination between 2000 and 2002 16, 17 . 
Polysomnography and other sleep-related measures
In-home sleep studies using unattended polysomnography (Safiro, Compumedics, Inc., Melbourne, Australia) were performed. The recording montage consisted of C3/A2 and C4/A1 electroencephalograms, bilateral electrooculograms, a bipolar submental electromyogram, thoracic and abdominal respiratory inductance plethysmography, airflow (using nasal-oral thermocouple and nasal pressure cannula), finger pulse oximetry, electrocardiogram, body position (mercury switch sensor), and bilateral leg movements (piezoelectric sensors). Trained certified staff members performed home visits for setup of the sleep study units.
After sensors were placed and calibrated, signal quality and impedance were checked, and sensors were repositioned as needed to improve signal quality, replacing electrodes if impedances were greater than 5 kΩ, using approaches similar to those in the Sleep Heart Health Study 19 . After studies were downloaded, they were transferred to the Case Reading Center (Cleveland, OH) for centralized scoring by a trained technician. Polysomnography data quality was excellent, with a failure rate of less than 4% and more than 70% of studies graded as being of excellent or outstanding quality. Quality codes for signals and studies were graded using previously described approaches, which included coding the duration of artifact-free data per channel and overall study quality (reflecting the combination of grades for each channel). We note that central apnea events were included in the overall apnea-hypopnea index (AHI), but such events were rare (only 7% of study participants had a central apnea index ≥5/hr).
Vitamin D analysis:
Serum 
Clinical data:
All covariate data were collected at the time of the sleep study visit. All participants completed questionnaire data, which included questions about medical history, smoking, and alcohol intake. Hypertension was defined as a positive response to the question, "Has a doctor or other healthcare provider told you that you have hypertension or high blood pressure?". Race was based on selfreport and categorized as Caucasian, African American, Asian, or Hispanic/other.
BMI was calculated as weight (kg)/height (m 2 ), and obesity was defined as a BMI greater than 30 kg/m 2 . During the home or clinic visits, body weight was measured using a standard balance beam scale and height using a wall-mounted
Harpenden stadiometer (Holtain, UK). Neck and waist circumference were also measured using standard methods. Snoring was assessed according to self-report.
The MacArthur Subjective Status Scale (range 1-10) was used to assess perceived social status, with higher scores representing higher perceived social status.
Participants were asked to bring in all current medications used within the preceding 30 days. All prescription and non-prescription medications were entered into an electronic database and each medication was matched to its ingredient(s) based on the Iowa Drug Information Service (IDIS) Drug Vocabulary (College of Pharmacy, University of Iowa, Iowa City, IA). A variable for season (January-March=Winter; April-June=Spring; JulySeptember=Summer; October-December=Fall) was calculated using the date of the participant's clinic exam.
Statistical analysis:
In primary analyses, we expressed 25(OH)D concentrations in quartiles and compared baseline characteristics across quartiles using analysis of variance or Also similar to our findings, the AHI difference was no longer significant after adjusting for covariates such as age, gender, and waist circumference. In exploratory analyses, the authors found that AHI was higher by 7.1 events/hour in Our study has some inherent limitations as well. Our study participants were generally healthy, largely Caucasian, elderly males, so we cannot generalize these findings to non-Caucasians, females and younger patients. This was also a cross- Lastly, we note that some data suggest that myopathy related to vitamin D deficiency may be most pronounced at very low 25(OH)D concentrations such as <12 ng/mL 31 . Because our community-dwelling cohort had very few persons with such low levels (only 2.1% had concentrations <12 ng/mL), our study is not able to adequately address whether profound vitamin D deficiency could be independently associated with OSA.
Conclusions:
Among community-dwelling older men, the association between lower serum 25(OH)D concentrations and higher odds of sleep apnea was explained by greater BMI and larger neck circumference among those with lower 25(OH)D levels. 
